Low-dose valganciclovir is efficacious and safe for prophylaxis of cytomegalovirus infection in kidney transplantation

被引：0
|
作者：
Perrottet, Nancy [1 ]
Manuel, Oriol [4 ]
Venetz, Jean-Pierre [2 ]
Lamoth, Frederic [2 ]
Decosterd, Laurent A. [1 ]
Buclin, Thierry [1 ]
Biollaz, Jerome [1 ]
Meylan, Pascal [3 ]
Pascual, Manuel [2 ]
机构：
[1] Univ Hosp CHUV, Clin Pharmacol & Toxicol, Lausanne, Switzerland
[2] Univ Hosp CHUV, Organ Transplant Ctr, Lausanne, Switzerland
[3] Univ Hosp CHUV, Inst Microbiol, Lausanne, Switzerland
[4] Univ Alberta, Edmonton, AB, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [1] Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
    Ozcelik, Umit
    Alpay, Nadir
    Eren, Eryigit
    Uslu, Bora
    Yardimci, Ahmet Cem
    [J]. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2020, 58 (01): : 27 - 32
  • [2] Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Organ Transplantation: Is Less Really More?
    Avery, Robin K.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) : 322 - 324
  • [3] Selective low-dose valganciclovir for prevention of cytomegalovirus disease following kidney transplantation
    Avidan, Yafit Partouche
    Paul, Mical
    Rahamimov, Ruth
    Bishara, Jihad
    Samra, Zmira
    Edna, Scherf
    Mor, Eytan
    [J]. JOURNAL OF INFECTION, 2008, 57 (03) : 236 - 240
  • [4] Low-dose valganciclovir for cytomegalovirus prophylaxis in intermediate-risk liver transplantation recipients
    Khan, Salman
    Sullivan, Timothy
    Ali, Mohsin
    Dunn, Dallas
    Patel, Gopi
    Huprikar, Shirish
    [J]. LIVER TRANSPLANTATION, 2018, 24 (05) : 616 - 622
  • [5] Does Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis Affect Outcomes in Kidney Transplant Recipients?
    Gillespie, M.
    Smith, L.
    Lee, S.
    Kenyon, N.
    Truax, C.
    Corbett, J.
    Shihab, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 322 - 322
  • [6] Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Heart Transplant Recipients
    Julian, K. G.
    Shattahi, E.
    Burg, J. E.
    Boehmer, J. P.
    [J]. TRANSPLANTATION PROCEEDINGS, 2013, 45 (09) : 3414 - 3417
  • [7] Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis
    Farkas, Katalin
    Varga, Marina
    Dinnyes, Izabella
    Rem, Lili
    Telkes, Gabor
    Wagner, Laszlo
    Remport, Adam
    Piros, Laszlo
    Szijarto, Attila
    Huszty, Gergely
    [J]. TRANSPLANTATION PROCEEDINGS, 2024, 56 (01) : 105 - 110
  • [8] Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin
    Eriksson, Mari
    Jokinen, Janne J.
    Soderlund, Sanni
    Hammainen, Pekka
    Lommi, Jyri
    Lemstrom, Karl
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (03)
  • [9] VALGANCICLOVIR UNIVERSAL PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN HEART TRANSPLANTATION
    Vymetalova, Jevgenija
    Skalicka, Blanka
    Gazdic, Tomas
    Vrbska, Jana
    Malek, Ivan
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 137 - 137
  • [10] Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation
    Klem, P.
    Al-Omar, L.
    Cooper, J.
    Davis, S.
    Gralla, J.
    Choe, D.
    Wiseman, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 468 - 468
12345